» Articles » PMID: 21106671

Bcl-6 and NF-kappaB Cistromes Mediate Opposing Regulation of the Innate Immune Response

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2010 Nov 26
PMID 21106671
Citations 165
Authors
Affiliations
Soon will be listed here.
Abstract

In the macrophage, toll-like receptors (TLRs) are key sensors that trigger signaling cascades to activate inflammatory programs via the NF-κB gene network. However, the genomic network targeted by TLR/NF-κB activation and the molecular basis by which it is restrained to terminate activation and re-establish quiescence is poorly understood. Here, using chromatin immunoprecipitation sequencing (ChIP-seq), we define the NF-κB cistrome, which is comprised of 31,070 cis-acting binding sites responsive to lipopolysaccharide (LPS)-induced signaling. In addition, we demonstrate that the transcriptional repressor B-cell lymphoma 6 (Bcl-6) regulates nearly a third of the Tlr4-regulated transcriptome, and that 90% of the Bcl-6 cistrome is collapsed following Tlr4 activation. Bcl-6-deficient macrophages are acutely hypersensitive to LPS and, using comparative ChIP-seq analyses, we found that the Bcl-6 and NF-κB cistromes intersect, within nucleosomal distance, at nearly half of Bcl-6-binding sites in stimulated macrophages to promote opposing epigenetic modifications of the local chromatin. These results reveal a genomic strategy for controlling the innate immune response in which repressive and inductive cistromes establish a dynamic balance between macrophage quiescence and activation via epigenetically marked cis-regulatory elements.

Citing Articles

NF-κB RelB suppresses the inflammatory gene expression programs of dendritic cells by competing with RelA for binding to target gene promoters.

Navarro H, Daly A, Rodriguez B, Wu S, Ngo K, Fraser A Cell Discov. 2025; 11(1):13.

PMID: 39929805 PMC: 11811218. DOI: 10.1038/s41421-024-00767-9.


The human milk oligosaccharide 3'sialyllactose reduces low-grade inflammation and atherosclerosis development in mice.

Pessentheiner A, Spann N, Autran C, Oh T, Grunddal K, Coker J JCI Insight. 2024; 9(21).

PMID: 39325548 PMC: 11601559. DOI: 10.1172/jci.insight.181329.


Repeated LPS induces training and tolerance of microglial responses across brain regions.

Kim J, Sullivan O, Lee K, Jao J, Tamayo J, Madany A J Neuroinflammation. 2024; 21(1):233.

PMID: 39304952 PMC: 11414187. DOI: 10.1186/s12974-024-03198-1.


Examining NF-κB genomic interactions by ChIP-seq and CUT&Tag.

Daly A, Schiffman A, Hoffmann A, Smale S bioRxiv. 2024; .

PMID: 39185161 PMC: 11343132. DOI: 10.1101/2024.08.11.607521.


Selective regulation of a defined subset of inflammatory and immunoregulatory genes by an NF-κB p50-IκBζ pathway.

Daly A, Yeh G, Soltero S, Smale S Genes Dev. 2024; 38(11-12):536-553.

PMID: 38918046 PMC: 11293394. DOI: 10.1101/gad.351630.124.


References
1.
Parekh S, Polo J, Shaknovich R, Juszczynski P, Lev P, Ranuncolo S . BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. Blood. 2007; 110(6):2067-74. PMC: 1976344. DOI: 10.1182/blood-2007-01-069575. View

2.
Scott E, Simon M, Anastasi J, Singh H . Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994; 265(5178):1573-7. DOI: 10.1126/science.8079170. View

3.
Takeuchi O, Akira S . Pattern recognition receptors and inflammation. Cell. 2010; 140(6):805-20. DOI: 10.1016/j.cell.2010.01.022. View

4.
Dhordain P, Albagli O, Lin R, Ansieau S, Quief S, Leutz A . Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Natl Acad Sci U S A. 1997; 94(20):10762-7. PMC: 23478. DOI: 10.1073/pnas.94.20.10762. View

5.
Niu H, Ye B, Dalla-Favera R . Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 1998; 12(13):1953-61. PMC: 316953. DOI: 10.1101/gad.12.13.1953. View